Company patents

Imperative Care, Inc.

Imperative Care, Inc. demonstrates a strong focus on core medical device areas, with Drug Delivery Devices (74.8% of portfolio) and Medical Diagnostics & Surgery (69.2% of portfolio) dominating its patent strategy. While both categories saw significant year-over-year growth in 2024 (+23.8% and +42.1% respectively), the notable decline in patenting activity across all categories in 2025 and so far in 2026, particularly in Implants & Prosthetics which saw a 100.0% drop in 2026 after a 200.0% surge in 2025, suggests a potential strategic re-evaluation or a shift in R&D priorities.

Patent Trend by Technology Area

Yearly patent publications since 2023

Product themes

Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.

107 US filings (since 2023) · 4 categories · 5 themes

Patents

Showing 11-20 of 131

Page 2 of 14